Trial NCT01212094

View at ClinicalTrials.gov 
Org. Study IDs: 100212
Secondary IDs: 10-N-0212

Last trial update was posted on 2016-03-28

MeSH Interventions

Rituximab

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Sclerosis

Other Conditions


Stopping Reasons

The efficacy on CSF biomarkers failed to reach criteria for continuation of the trial

Limitations And Caveats

The trial was closed prematurely for futility, because pre-determined interim analysis demonstrated that selected dosing led to <50% depletion of B cells from the brain/spinal cord. Therefore, only 5 patients per group finished trial.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID